Watch Live

Tweet TWEET

Elsevier Launches New Open Access Journal: Leukemia Research Reports

     Elsevier Launches New Open Access Journal: Leukemia Research Reports

  PR Newswire

  OXFORD, England, November 22, 2012

OXFORD, England, November 22, 2012 /PRNewswire/ --

  A new forum for short communications of  clinical research in leukemias,
        lymphomas, multiple myeloma and other hematologic malignancies

Elsevier , a world-leading provider of scientific, technical and medical
information products and solutions, is pleased to announce the launch of a new
open access, online journal, Leukemia Research Reports .

Leukemia Research Reports, a sister journal to the prestigious publication
Leukemia Research, will deliver timely information online to all health care
professionals involved in basic and/or applied clinical research in leukemias,
lymphomas, multiple myeloma and other hematologic malignancies. It will
fulfill this role by rapidly publishing a range of peer-reviewed short form
papers, including brief communications, case reports, letters to the editors,
images and debate articles.

The editors of Leukemia Research Reports are: Dr Suneel Mundle (Janssen
Services LLC and Rush Medical College, Chicago, IL) and Dr Meir Wetzler (State
University of New York at Buffalo School of Medicine and Roswell Park Cancer
Center, Buffalo, NY). 

The editors encourage the submission of articles relevant to normal and
leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular
biology as well as epidemiologic and clinical studies. C overage will
encompass the application of oncogenes, genomics (gene expression profiles,
microRNAs), proteomics growth factors, cell markers, cell cycle and
differentiation agents, novel therapeutics and clinical trials in both the
acute and chronic leukemias as well as the myelodysplastic syndromes. In
addition articles are solicited on the rapidly growing specialty of marrow or
stem cell reconstitution after high dose therapy with curative attempt in
patients with a wide range of neoplasms.

For more information or to submit an article, go to
http://www.journals.elsevier.com/leukemia-research-reports . First articles
published in the journal are now available online through ScienceDirect.

About Elsevier Elsevier is a world-leading provider of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet and Cell , and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier's
online solutions include ScienceDirect , Scopus , Reaxys , ClinicalKey and
Mosby's Nursing Suite , which enhance the productivity of science and health
professionals, and the SciVal suite and MEDai's Pinpoint Review , which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact Rachel Garland Elsevier +44(0)1865-843113 r.garland@elsevier.com
 
Press spacebar to pause and continue. Press esc to stop.